Implications of the KIWE trial for low-income and lower-middle-income countries

Lancet Neurol. 2024 Apr;23(4):332. doi: 10.1016/S1474-4422(24)00054-1.

Authors

Jitendra Kumar Sahu¹, Priyanka Madaan², Jithangi Wanigasinghe³, Pauline Samia⁴; South Asia allied IESS Research Group

Collaborators

South Asia allied IESS Research Group:
Aye Mya Min Aye, Esmatullah Hamed, Kanij Fatema, Kyaw Linn, Mimi L Mynak, Nicolás Garófalo Gómez, Prakash Poudel, Prem Chand, Samaahath Hassan

Affiliations

¹ Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical; Education and Research, Chandigarh, India. Electronic address: jsh2003@gmail.com.
² Department of Pediatric Neurology, Amrita Institute of Medical Sciences, Faridabad, India.
³ Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
⁴ Department of Paediatrics and Child Health, Medical College, Aga Khan University, Nairobi, Kenya.

PMID: 38508824
DOI: 10.1016/S1474-4422(24)00054-1

No abstract available

Publication types

Letter

MeSH terms

Developing Countries*
Humans
Poverty*
Risk Factors